BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 30209635)

  • 1. Atrial Cardiopathy and Stroke Prevention.
    Elkind MSV
    Curr Cardiol Rep; 2018 Sep; 20(11):103. PubMed ID: 30209635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation.
    Kamel H; Okin PM; Longstreth WT; Elkind MS; Soliman EZ
    Future Cardiol; 2015 May; 11(3):323-31. PubMed ID: 26021638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial cardiopathy: a mechanism of cryptogenic stroke.
    Yaghi S; Kamel H; Elkind MSV
    Expert Rev Cardiovasc Ther; 2017 Aug; 15(8):591-599. PubMed ID: 28718666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of Atrial Cardiopathy and Atrial Fibrillation Detection on Mobile Outpatient Continuous Telemetry After Embolic Stroke of Undetermined Source.
    Sebasigari D; Merkler A; Guo Y; Gialdini G; Kummer B; Hemendinger M; Song C; Chu A; Cutting S; Silver B; Elkind MSV; Kamel H; Furie KL; Yaghi S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1249-1253. PubMed ID: 28237125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Left Atrial Appendage Amputation During Routine Cardiac Surgery Reduce Future Atrial Fibrillation and Stroke?
    Domínguez H; Madsen CV; Westh ONH; Pallesen PA; Carrranza CL; Irmukhamedov A; Park-Hansen J
    Curr Cardiol Rep; 2018 Aug; 20(10):99. PubMed ID: 30171381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study).
    Goldman ME; Pearce LA; Hart RG; Zabalgoitia M; Asinger RW; Safford R; Halperin JL
    J Am Soc Echocardiogr; 1999 Dec; 12(12):1080-7. PubMed ID: 10588784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Left Atrial Appendage Ligation for Stroke Prevention in Atrial Fibrillation.
    Valderrábano M; Price MJ
    Methodist Debakey Cardiovasc J; 2015; 11(2):94-9. PubMed ID: 26306126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary prognosis after cardioembolic stroke of atrial origin: the role of left atrial and left atrial appendage dysfunction.
    Panagiotopoulos K; Toumanidis S; Vemmos K; Saridakis N; Stamatelopoulos S
    Clin Cardiol; 2003 Jun; 26(6):269-74. PubMed ID: 12839044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi.
    Stöllberger C; Chnupa P; Kronik G; Brainin M; Finsterer J; Schneider B; Slany J
    Ann Intern Med; 1998 Apr; 128(8):630-8. PubMed ID: 9537936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atrial fibrillation and stroke].
    Mattle HP; Schwerzmann M; Seiler Ch
    Ther Umsch; 2003 Sep; 60(9):527-34. PubMed ID: 14579621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical discordance of the left atrium and appendage: a novel mechanism of stroke in paroxysmal atrial fibrillation.
    Warraich HJ; Gandhavadi M; Manning WJ
    Stroke; 2014 May; 45(5):1481-4. PubMed ID: 24643411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation and stroke: how much atrial fibrillation is enough to cause a stroke?
    Healey JS; Amit G; Field TS
    Curr Opin Neurol; 2020 Feb; 33(1):17-23. PubMed ID: 31809335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Atrial Appendage and Closure: Who, When, and How.
    Holmes DR; Reddy VY
    Circ Cardiovasc Interv; 2016 May; 9(5):e002942. PubMed ID: 27139910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain natriuretic peptide as a surrogate marker for cardioembolic stroke with paroxysmal atrial fibrillation.
    Naya T; Yukiiri K; Hosomi N; Takahashi T; Ohkita H; Mukai M; Koziol JA; Kohno M
    Cerebrovasc Dis; 2008; 26(4):434-40. PubMed ID: 18799875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators.
    Ann Intern Med; 1992 Jan; 116(1):6-12. PubMed ID: 1727097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticoagulant treatment in the prophylaxis of thromboembolic complications in atrial fibrillation].
    Skrakova M; Sujanova Z
    Bratisl Lek Listy; 2001; 102(5):268-70. PubMed ID: 11725382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke risk and antithrombotic strategies in atrial fibrillation.
    Medi C; Hankey GJ; Freedman SB
    Stroke; 2010 Nov; 41(11):2705-13. PubMed ID: 20930160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.